Blackstone, TPG Complete $17B Hologic Acquisition

Hologic Inc., a leading women's health technology company based in Marlborough, Massachusetts, completed its shift to private ownership on April 7, 2026, following a $17 billion acquisition by funds managed by Blackstone and TPG. The deal, valued at up to $79 per share, marks one of the largest transactions in the medical device sector in recent years and ends Hologic's nearly four decades as a publicly traded entity.

The acquisition was first announced on October 21, 2025, and received approval from stockholders on February 5, 2026, after clearing all regulatory hurdles, including approvals from authorities in China. Shareholders received $76 in immediate cash per share, along with a non-transferable contingent value right potentially worth an additional $3 per share. This contingent payment is structured in two installments of up to $1.50 each, payable only if Hologic meets specific global revenue targets for its Breast Health segment in fiscal years 2026 and 2027. The full value of the deal thus hinges on the company's performance in this key area, which includes breast imaging and diagnostics products.

Minority investments in the transaction came from a subsidiary of the Abu...